英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
Atorvastatin 2-Fluoro t-Butyl Ester
|
1099474-28-8 |
Atorvastatin 2-Fluoro t-Butyl Ester
|
|
C40H47FN2O5 |
654.823 | |
(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate
|
866607-35-4 |
卡格列净中间体2
|
卡格列净中间体2;卡格列净四乙酸盐;卡格列净杂质05;(1S)-1,5-脱水-1-C-[3-[[5-(4-氟苯基)-2-噻吩基]甲基]-4-甲基苯基]-D-山梨糖醇四乙酸酯;坎格列净四乙酸酯;卡格列净四乙酸酯;CANAGLIFLOZIN-2
|
C32H33FO9S |
612.662423 | 617-901-5 |
Tert-Butyl methyl-D3 ether
|
29366-08-3 |
叔丁基甲基-D3醚
|
叔丁基甲基-D3醚
|
C5H9D3O |
91.17 | 686-114-7 |
Tert-Butyl methyl ether D12
|
284487-64-5 |
氘代12叔丁基甲醚
|
氘代12叔丁基甲醚;甲基叔丁基醚-D12
|
C5D12O |
100.22 | 216-653-1 |
Salbutamol Impurity N (Albuterol Dimer)
|
149222-15-1 |
沙丁胺醇杂质N
|
沙丁胺醇杂质N;沙丁胺醇二聚体;沙丁胺醇EP杂质N(丁烯醇二聚体);沙丁胺醇杂质N对照品;沙丁胺醇EP杂质N(沙丁胺醇二聚体);沙丁胺醇EP杂质N
|
C26H40N2O5 |
460.6062 | |
4-BenzylAlbuterol
|
56796-66-8 |
沙丁胺醇杂质I
|
硫酸沙丁胺醇BP杂质I;沙丁胺醇EP杂质I;沙丁胺醇中间体OBS
|
C20H27NO3 |
329.43328 | 260-385-8 |
Salbutamol Impurity C (Albuterol Related Compound A)
|
18910-68-4 |
沙丁胺醇杂质C
|
3-脱氧沙丁胺醇;左沙丁胺醇相关物质B;沙丁胺醇杂质C对照品;沙丁胺醇EP杂质C
|
C14H22NO2P |
267.303741 | |
Salbutamol Impurity B
|
96948-64-0 |
沙丁胺醇EP杂质B
|
沙丁胺醇EP杂质B
|
C12H19NO2 |
209.28476 | |
Roxithromycin EP Impurity D
|
134931-00-3 |
罗红霉素杂质D
|
罗红霉素杂质D;罗红霉素EP杂质D
|
C41H76N2O15 |
837.04654 | 617-007-5 |
Nicotine-d4
|
350818-69-8 |
氘代烟碱
|
尼古丁-D4;氘代烟碱;烟碱D4
|
C10H10D4N2 |
166.26 | 694-354-9 |
PHOSPHORIC ACID-D3
|
14335-33-2 |
磷酸-d3
|
氚代磷酸;三氘磷酸;氘代磷酸重水溶液;磷酸-D3(100G );磷酸-D3 溶液;三氘代磷酸;氘代磷酸;磷酸-D3
|
D3O4P |
101.01 | 238-285-0 |
Phenol-d6
|
13127-88-3 |
苯酚-D6
|
苯酚-D6;六氘苯酚;苯酚-D6,98 原子%D;六氘代苯酚;苯酚-D6 5G;[(1R,4S)-4-[2-AMINO-6-(CYCLOPROPYLAMINO)-9H-PURIN-9-YL]CYCLOPENT-2-ENYL]METHANOL;苯酚-D6 标准品
|
C6D6O |
100.15 | 236-063-8 |
Perylene-d12
|
1520-96-3 |
北-D12
|
北-D12;氘代苝;二萘嵌苯-D12;-D12 溶液;二氯甲烷中苝-D12;苝-D12 标准品
|
C20D12 |
264.38 | 200-838-9 |
Palmitic acid-2,2-d2
|
62689-96-7 |
氘代十六烷酸(2,2,-D2)
|
氘代十六烷酸(2,2,-D2);十六酸-2,2-D2;棕榈酸-2,2-D2
|
C16H30D2O2 |
258.44 | |
NaBD4
|
1020719-68-9 |
氘代N-亚硝基假木贼碱
|
NABETA-D4;(R,S)-N-NITROSOANABASINE-D4;NAB-d4;5-(1-Nitroso-2-piperidinyl)pyridine-2,3,4,6-d4;(R,S)-N-Nitroso Anabasine-d4 (0.1 Mg/ML in Methanol);5-(1-Nitroso-2-piperidinyl)pyridine-2,3,4,6-d4
|
C10H9D4N3O |
195.25 | |
Mono-poc tenofovir
|
211364-69-1 |
单POC泰诺福韦(非对映体的混合物)
|
TENOFOVIR DISOPROXIL FUMARATE RELATED SUBSTANCE 泰诺福韦酯相关物质;替诺福韦地索普西相关化合物E;单POC泰诺福韦(非对映体的混合物);替诺福韦单吡呋酯;({[(R)-1-(6-氨基-9H-嘌呤-9-基)丙-2-基氧基]甲基}(羟基)膦酰基氧基)甲基异丙基碳酸酯;单POC泰诺福韦(非对映体的混合物)(泰诺福韦酯杂质E);泰诺福韦酯杂质E;泰诺福韦单异丙氧羰基氧甲基酯
|
C14H22N5O7P |
403.327541 | |
methyl-D3-amine hydrochloride
|
7436-22-8 |
氘代甲胺盐酸盐
|
甲胺-D3 盐酸盐;甲基-D3-胺 盐酸盐;甲基-D3-氯化铵;氘代甲胺盐酸盐
|
CH3ClD3N |
70.54 | 231-089-6 |
METHANOL-D4
|
811-98-3 |
氘代甲醇
|
氘代甲醇 10×0.55ML;甲醇-D4 99.8原子%D;氘代甲醇-4D;氘甲醇;氘代甲醇-D{4},100%(同位素);氘代甲醇,含TMS;氘代甲醇-D{4},99.8%(ISOTOPIC);氘代甲醇,99.8%(ISOTOPIC),CONTAINS 0.05% V;V TMS
|
CD4O |
36.07 | 212-378-6 |
Linagliptin Impurity 18
|
668273-74-3 |
利格列汀杂质S
|
Linagliptin Impurity S;8-(3-aminopiperidin-1-yl)-7-(3-chlorobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
|
|||
Linagliptin impurity K
|
1638744-06-5 |
利格列汀杂质K
|
利格列汀杂质K;利拉利汀杂质K
|
C25H29BrN8O2 |
553.5 |